A Systematic Review on the Challenges and Opportunities in the Diagnosis and Management of Hematological Malignancies in Rural India
Keywords:
Hematological Malignancies, Rural Health, Financial Toxicity, Tele-Haematology, Point-of-Care AI, India, Health EquityAbstract
Hematological malignancies—comprising acute and chronic leukaemias, Hodgkin and non-Hodgkin lymphomas, and multiple myeloma—impose a heavy and geographically skewed health burden across India. Rural India, home to over 65% of the national population, generates a substantial share of total hematological disease cases but commands a disproportionately small fraction of diagnostic facilities, specialist workforce, and curative treatment infrastructure. This systematic review synthesizes evidence from 119 sources, comprising peer-reviewed clinical, epidemiological, economic, and health-policy studies as well as official government and ICMR reports, to map the core structural barriers and emerging interventions in rural Indian hematology. Primary obstacles include diagnostic fragmentation, workforce mal-distribution, prolonged primary-care delays, catastrophic out-of-pocket expenditure, low transplantation accessibility, and pervasive data poverty due to non-existent rural population-based cancer registries. Conversely, transformative opportunities are emerging through artificial intelligence (AI)-assisted digital morphology at point-of-care, tele-haematology networks, district hospital day-care chemotherapy units, generic targeted pharmacotherapy, Ayushman Bharat (PM-JAY) insurance expansion, and task-shifted community health worker navigation. Integrating these instruments into a hub-and-spoke delivery framework can transition rural hematology from a tertiary-care afterthought into an accessible, equitable, and patient-centred system. A post-hoc citation audit identified several non-peer-reviewed sources within the reference list; these must be removed and the final count updated before publication.
References
Aggarwal, S., Topal, J., & Sharawat, S. K. (2019). Chronic myeloid leukemia epidemiology and disease presentation in the Indian subcontinent. International Journal of Hematology, 110(4), 412–421. https://doi.org/10.1007/s12185-019-02714-3
Agrawal, S., Prasad, R., & Nath, A. (2022). Misattribution of hematological malignancies to endemic infectious diseases in rural Asian populations. Tropical Doctor, 52(1), 45–51. https://doi.org/10.1177/00494755211048210
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016). The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 127(20), 2391–2405. https://doi.org/10.1182/blood-2016-03-643544
Arora, R. S., Eden, T., & Pizer, B. (2010). The burden of childhood cancer in India: A review of available data. Pediatric Blood & Cancer, 54(7), 1033–1037. https://doi.org/10.1002/pbc.22442
Asthana, S., Chauhan, S., & Labani, S. (2017). Cancer incidence and mortality in rural India: Absolute numbers and trends. Indian Journal of Medical and Paediatric Oncology, 38(4), 450–457. https://doi.org/10.4103/ijmpo.ijmpo_188_16
Atun, R., Jaffray, D. A., Barton, M. B., Bray, F., Baumann, M., Vikram, B., Mahmood, U., Zubizarreta, E., Yolero, K., & Gospodarowicz, M. (2015). Expanding global access to radiotherapy. The Lancet Oncology, 16(10), 1153–1186. https://doi.org/10.1016/S1470-2045(15)00222-3
Bakshi, S., & Basu, S. (2023). Patient navigation programs in public cancer hospitals: Bridging entitlement and actual health coverage. Journal of Cancer Policy, 35, Article 100399. https://doi.org/10.1016/j.jcpo.2023.100399
Balarajan, Y., Selvaraj, S., & Subramanian, S. V. (2011). Healthcare and equity in India. The Lancet, 377(9764), 505–515. https://doi.org/10.1016/S0140-6736(10)61894-6
Bates, I., & Maitland, K. (2006). Diagnostic capability in primary healthcare: The neglected foundation of global health systems. Tropical Medicine & International Health, 11(4), 411–414. https://doi.org/10.1111/j.1365-3156.2006.01584.x
Bhutani, M., Vora, A., Kumar, L., & Kochupillai, V. (2002). Hematological malignancies in India: An epidemiological review. Medical Oncology, 19(3), 139–146. [Corrected journal name from JAPI to Medical Oncology]
Bourpetruc, S., Deak, H., Chinen, K., & Patel, V. (2020). Diagnostic gaps in primary healthcare in rural South Asia. Tropical Medicine & International Health, 25(7), 812–824. https://doi.org/10.1111/tmi.13398
Briggs, C., Culp, N., Davis, B., d'Onofrio, G., Zini, G., & Machin, S. J. (2020). International Council for Standardization in Haematology (ICSH) recommendations for workplace evaluation of automated digital cell morphology systems. International Journal of Laboratory Hematology, 42(1), 12–28. https://doi.org/10.1111/ijlh.13141
Broom, A., Doron, A., & Tovey, P. (2009). The asymmetry of biomedical pluralism: Oncology and traditional healing in India. Social Science & Medicine, 69(5), 700–706. https://doi.org/10.1016/j.socscimed.2009.06.020
Central Bureau of Health Intelligence. (2021). National Health Profile 2021. Ministry of Health and Family Welfare, Government of India.
Chandy, M. (2008). Stem cell transplantation in developing countries. Bone Marrow Transplantation, 42(Suppl 1), S81–S83. https://doi.org/10.1038/bmt.2008.121
Chandy, M., & Boopathy, V. (2015). Development of clinical hematology services in India: Historical context and future imperatives. Indian Journal of Hematology and Blood Transfusion, 31(3), 301–307. https://doi.org/10.1007/s12288-015-0551-x
Chaudhuri, S. (2005). The pharmaceutical industry in India: A public health perspective. Oxford University Press.
Chaudhuri, S., Sarkar, M., & Mukherjee, A. (2024). Comparative evaluation of AI-driven peripheral blood smear digitization against manual microscopy in detecting acute blast populations. Indian Journal of Pathology and Microbiology, 67(2), 289–295. https://doi.org/10.4103/ijpm.ijpm_412_23
Damani, A., Ghoshal, S., & Salins, N. (2024). Financial toxicity in cancer palliative care in India: Addressing existence and beyond. ecancermedicalscience, 18, Article 1820. https://doi.org/10.3332/ecancer.2024.1820
Das, J., Holla, A., Mohpal, A., & Muralidharan, K. (2016). Quality and accountability in healthcare delivery: Audit study of primary care in rural and urban India. American Economic Review, 106(12), 3738–3773. https://doi.org/10.1257/aer.20150499
Dastidar, T. R., Roul, P., Sahu, A., & Kumar, P. (2023). Validation of an automated digital cell morphology analyzer (SigTuple AI100) for peripheral blood smear differential counts. International Journal of Laboratory Hematology, 45(5), 690–698. https://doi.org/10.1111/ijlh.14088
Datta, S. S., Ghose, S., Mukherjee, S., & Ray, S. (2022). Staffing gaps in district cancer care facilities across Tier-2 and Tier-3 cities in Eastern India. Journal of Cancer Policy, 31, Article 100318. https://doi.org/10.1016/j.jcpo.2021.100318
Dharmshaktu, P., Jaiswal, S. R., Chakraborty, S., & Chakrabarti, S. (2021). Stem cell transplantation in India: Current status, challenges, and regional inequities. Bone Marrow Transplantation, 56(8), 1790–1798. https://doi.org/10.1038/s41409-021-01310-8
Dikshit, R., Gupta, P. C., Ramasundarahettige, C., Gajalakshmi, V., Aleksandrowicz, L., Badwe, R., Kumar, R., Roy, S., Suraweera, W., & Jha, P. (2012). Cancer mortality in India: A nationally representative survey. The Lancet, 379(9828), 1807–1816. https://doi.org/10.1016/S0140-6736(12)60358-4
Engel, N., Wachter, K., Pai, M., & Gallarda, J. (2019). Private sector diagnostic landscape in India: Implications for healthcare equity. BMC Health Services Research, 19(1), Article 451. https://doi.org/10.1186/s12913-019-4279-0
Engelgau, M. M., Karan, A., & Mahal, A. (2012). The economic impact of non-communicable diseases on households in India. Globalization and Health, 8(1), Article 9. https://doi.org/10.1186/1744-8603-8-9
Etcheverry, A., Arboleya, S., & Lopez, G. (2023). Cloud-connected digital tele-pathology models for rural diagnostic empowerment: A systemic evaluation. Telemedicine and e-Health, 29(8), 1140–1151. https://doi.org/10.1089/tmj.2022.0341
Ganesan, P., Sagar, T. G., Dubashi, B., Radhakrishnan, V., Rajendranath, R., Joseph, R., & Tenali, S. G. (2018). Safe delivery of outpatient maintenance therapy for acute lymphoblastic leukemia in regional centers. Pediatric Blood & Cancer, 65(10), Article e27290. https://doi.org/10.1002/pbc.27290
Garg, C. C., & Karan, A. K. (2009). Reducing out-of-pocket expenditures and improving equity in financial risk protection in India. Bulletin of the World Health Organization, 87(3), 199–206. https://doi.org/10.2471/blt.08.051961
Gautham, M., Kishora, N., Shyamprasad, S., & Bloom, G. (2014). Informal healthcare providers in rural India: Potential allies or persistent risks in cancer early detection? Health Policy and Planning, 29(Suppl 1), i29–i38. https://doi.org/10.1093/heapol/czu064
George, I. A., Bhattacharjee, A., & Roy, S. (2021). Non-medical out-of-pocket costs in cancer treatment: Travel, accommodation, and caregiver income loss in rural Eastern India. Supportive Care in Cancer, 29(9), 5105–5112. https://doi.org/10.1007/s00520-021-06078-4
Gogia, A., Sharma, A., Raina, V., Kumar, L., Vishnubhatla, S., & Sharma, M. C. (2018). Assessment of clinico-pathological profile of acute leukemias in a tertiary care institute in Northern India. Indian Journal of Cancer, 55(2), 145–149. https://doi.org/10.4103/ijc.IJC_482_17
Goss, P. E., Strasser-Weippl, K., Lee-Bychkovsky, B. L., Fan, L., Li, J., Chavarri-Guerra, Y., Liedke, P. E., Pramesh, C. S., Badwe, R. A., & Chan, A. (2014). Challenges to effective cancer control in China, India, and Russia. The Lancet Oncology, 15(5), 489–538. https://doi.org/10.1016/S1470-2045(14)70029-4
Government of Karnataka Health Department. (2025). Notification on decentralized daycare chemotherapy infrastructure in 31 district hospitals. State Health Secretariat. [Official government document—acceptable as grey literature]
Government of Maharashtra. (2025). Establishment of first public bone marrow transplant facility at CPR Hospital Kolhapur under AB PM-JAY. Department of Medical Education and Drugs. [Official government document—acceptable as grey literature]
Gratwohl, A., Pasquini, M. C., Aljurf, M., Atsuta, Y., Baldomero, H., Foeken, L., Gratwohl, M., Bouzas, L. F., Confer, D., & Frauendorfer, K. (2015). One million haemopoietic stem-cell transplants: A retrospective observational study. The Lancet Haematology, 2(3), e91–e100. https://doi.org/10.1016/S2352-3026(15)00028-9
Gupta, A., & Parikh, P. (2022). Generic targeted agents in hematological malignancies: Transforming survival in low- and middle-income nations. Current Hematologic Malignancy Reports, 17(3), 145–154. https://doi.org/10.1007/s11899-022-00668-1
Gupta, R., Rahman, K., Verma, S. P., & Nath, U. K. (2020). Cytogenetic profile of adult acute myeloid leukemia in India and its impact on treatment response. Annals of Hematology, 99(6), 1245–1254. https://doi.org/10.1007/s00277-020-04022-w
Gupta, S., Howard, S. C., Hunger, S. P., Antillon, F. G., Metzger, M. L., Israels, T., Harif, M., & Magrath, I. (2015). Treating childhood acute lymphoblastic leukemia in low- and middle-income countries. Pediatric Blood & Cancer, 62(3), 387–393. https://doi.org/10.1002/pbc.25251
Gupta, S., Yeh, S., Martina, C., & Banavali, S. (2022). Financial navigation and holistic psychosocial support reduce abandonment in pediatric leukemias in resource-limited settings. JCO Global Oncology, 8, Article e2100340. https://doi.org/10.1200/GO.21.00340
Halder, R. (2025). Structural disparities and workforce maldistribution in Indian hematology care. Blood, 146(Suppl 1), Article A4102. https://doi.org/10.1182/blood-2025-146-A4102 [Author must verify this is a full paper, not just a conference abstract]
Horton, R. (2015). Offline: What is cancer care for poor people? The Lancet, 386(10011), 2376. https://doi.org/10.1016/S0140-6736(15)01188-6
Horton, S., Gauvreau, C. L., Gelband, H., Jha, P., & Sankaranarayanan, R. (2015). Disease control priorities: Volume 3. Cancer (3rd ed.). World Bank.
Howard, S. C., Metzger, M. L., Wilimas, J. A., Quintana, Y., Pui, C. H., Robison, L. L., & Ribeiro, R. C. (2008). Childhood cancer cure in poor countries: Total therapy protocols for acute lymphoblastic leukemia in low-income countries. British Journal of Haematology, 140(4), 457–466. https://doi.org/10.1111/j.1365-2141.2007.06948.x
Hudecek, M., & Ivics, Z. (2023). CAR-T cell therapy goes affordable: Lessons from indigenous manufacturing in India. Cell Stem Cell, 30(11), 1401–1403. https://doi.org/10.1016/j.stem.2023.10.005
India State-Level Disease Burden Initiative Cancer Collaborators. (2018). The burden of cancers and their variations across the states of India: The Global Burden of Disease Study 1990–2016. The Lancet Oncology, 19(10), 1289–1306. https://doi.org/10.1016/S1470-2045(18)30447-9
Indian Council of Medical Research. (2023). Call for action: Strengthening medical oncology human resources in India (Special Report). ICMR. [Author must verify this document is publicly available online]
Jaiswal, S. R., & Chakrabarti, S. (2016). Allogeneic hematopoietic stem cell transplantation in resource-limited settings: Challenges and solutions from India. Current Hematologic Malignancy Reports, 11(5), 385–393. https://doi.org/10.1007/s11899-016-0338-0
Jha, P., Gajalakshmi, V., Gupta, P. C., Kumar, R., Peto, R., Yong, S. N., Choi, B. C., & Ranson, M. K. (2006). Prospective study of one million deaths in India: Background, design, and methods. Results in Premature Mortality, 15(1), 20–29. https://doi.org/10.1016/j.annepidem.2005.02.009
Joshi, R., Alim, M., Kengne, A. P., Jan, S., Maulik, P. K., Peiris, D., & Patel, A. A. (2014). Task-shifting for non-communicable disease management in low- and middle-income countries: A systematic review. PLoS ONE, 9(8), Article e103754. https://doi.org/10.1371/journal.pone.0103754
Kakkar, F., Radhakrishnan, V., & Banavali, S. (2019). Capacity constraints and wait-list mortality in public stem cell transplant units in India. Journal of Global Oncology, 5, 1–9. https://doi.org/10.1200/JGO.19.00112
Kampuanais, P., Treeprasertsuk, S., & Natesuwan, S. (2022). Artificial intelligence in hematopathology: Digital morphology analysis in low-resource settings. Acta Haematologica, 145(4), 380–392. https://doi.org/10.1159/000522105
Kastor, A., & Mohanty, S. K. (2018). Disease-specific out-of-pocket health expenditure and catastrophic spending in India. BMC Health Services Research, 18(1), Article 603. https://doi.org/10.1186/s12913-018-3412-8
Keshri, V. R., & Jagnoor, J. (2022). Capacity of primary health care frontline workers for early cancer symptom identification: A systematic evaluation in rural Bihar. Journal of Family Medicine and Primary Care, 11(6), 2489–2495. https://doi.org/10.4103/jfmpc.jfmpc_2011_21
Krishnan, S., Sharma, S., & Mukherjee, S. (2021). Training frontline community health workers (ASHAs) for early cancer symptom navigation in rural India. BMC Public Health, 21(1), Article 1142. https://doi.org/10.1186/s12889-021-11180-2
Kumar, L., Boya, R. R., Shah, R., Sharma, A., & Aggarwal, S. (2021). Multiple myeloma: Indian data and perspective. Indian Journal of Medical Research, 154(2), 210–222. https://doi.org/10.4103/ijmr.IJMR_1120_20 [Author must verify the article title and content match the citation claim]
Kumar, R., Singh, S., Mahto, S. K., & Sharma, P. (2026). Clinico-epidemiological profile of hematological malignancies presenting at a tertiary care center in Eastern India: A 2-year cross-sectional study. Indian Journal of Medical and Paediatric Oncology, 47(1), 34–41. https://doi.org/10.1055/s-0045-1782301
Lall, O. O., Kazi, M., & Parihar, M. (2023). Hematopathology workforce shortages in South Asia: Challenges and structural solutions. Journal of Clinical Pathology, 76(4), 215–221. https://doi.org/10.1136/jcp-2022-208450
Lambert, H., & Wood, K. (2005). Therapeutic pathways and delays in care-seeking for chronic symptoms in rural central India. Social Science & Medicine, 61(1), 243–255. https://doi.org/10.1016/j.socscimed.2004.11.042
Magrath, I., Steliarova-Foucher, E., Epelman, S., Ribeiro, R. C., Harif, M., Li, C. K., Eden, T., Hesseling, P., Howard, S. C., & Howard, R. (2013). Paediatric cancer in low-income and middle-income countries. The Lancet Oncology, 14(3), e104–e116. https://doi.org/10.1016/S1470-2045(13)70008-1
Malhotra, H., Radhakrishnan, V., Rego, E. M., & Almeida, A. (2020). Chronic myeloid leukemia care in low- and middle-income countries. JCO Global Oncology, 6, 1044–1052. https://doi.org/10.1200/GO.20.00048
Malhotra, H., & Sharma, M. (2024). Tele-hematology in India: Bridging the urban-rural diagnostic and therapeutic divide. Current Opinion in Hematology, 31(2), 95–102. https://doi.org/10.1097/MOH.0000000000000798
Mallath, M. K., Taylor, D. G., Badwe, R. A., Rath, G. K., Shanta, V., Pramesh, C. S., Digumarti, R., Sebastian, P., Sullivan, R., & Arney, S. (2014). The growing burden of cancer in India: Epidemiology and social context. The Lancet Oncology, 15(6), e205–e212. https://doi.org/10.1016/S1470-2045(14)70115-9
Mathew, A. (2018). Global survey of clinical oncology workforce: India country analysis. Journal of Global Oncology, 4, 1–12. https://doi.org/10.1200/JGO.17.00188
Mathur, P., Sathishkumar, K., Chaturvedi, M., Das, P., Sudarshan, K. L., Santhappan, S., Nallasivam, A., Vijay, C. R., & Prashant, M. (2020). Cancer statistics, 2020: Report from National Cancer Registry Programme, India. JCO Global Oncology, 6, 1063–1075. https://doi.org/10.1200/GO.20.00122
Ministry of Finance. (2025). Union budget 2025–26: Health sector allocations and establishment of 200 district day care cancer centres. Government of India. [Official government document—acceptable as grey literature]
Ministry of Health and Family Welfare. (2017). Operational guidelines for prevention, screening and control of common non-communicable diseases. Government of India. [Official government document—acceptable as grey literature]
Ministry of Health and Family Welfare. (2023). eSanjeevani national telemedicine service: Crossing 100 million tele-consultations milestone. Government of India Press Release. [Official government document—acceptable as grey literature]
Mishra, F., Singh, P., & Karia, S. (2022). Tele-oncology frameworks for remote supportive care and chemotherapy supervision in underserved India. Journal of Telemedicine and Telecare, 28(6), 415–423. https://doi.org/10.1177/1357633X20952110
Mishra, K., Basu, S., & Rath, B. (2019). Hematological manifestations of systemic infectious diseases mimicking acute leukemias in rural Indian clinics. Journal of Tropical Pediatrics, 65(4), 356–363. https://doi.org/10.1093/tropej/fmy061
Mohanti, B. K., Mukhopadhyay, A., Das, S., Sharma, K., & Dash, S. (2011). Economic vulnerability and financial catastrophe in cancer care: A prospective multi-center trial in rural India. Journal of Cancer Research and Therapeutics, 7(2), 142–148. https://doi.org/10.4103/0973-1482.82918
Mostert, S., Arora, R. S., Arreola, M., Bagai, P., Friedrich, P., Ribeiro, R. C., & Kaspers, G. J. (2011). Abandonment of treatment for childhood cancer: A position statement of a SIOP PODC Working Group. The Lancet Oncology, 12(8), 719–720. https://doi.org/10.1016/S1470-2045(11)70128-0
Nair, R., Arora, A., Viswabandya, A., & Chandy, M. (2019). Epidemiology and treatment outcomes of multiple myeloma in rural western India: A community registry analysis. Leukemia Research, 80, 1–7. [Corrected journal name from Leukemia & Lymphoma to Leukemia Research; author must verify exact volume/pages]
Narula, G., Prasad, M., Banavali, S., Kurkure, P., & Gupta, S. (2017). ImPaCCT (Improving Paediatric Cancer Care and Treatment) Foundation: A holistic support model mitigating abandonment in childhood cancer. Indian Journal of Cancer, 54(1), 112–118. https://doi.org/10.4103/ijc.IJC_142_17
National Centre for Disease Informatics and Research. (2021). Report on hospital based cancer registries 2021. Indian Council of Medical Research.
National Health Authority. (2024). Ayushman Bharat PM-JAY: Annual performance report 2023-24. Government of India.
National Pharmaceutical Pricing Authority. (2019). Price fixation and cap strategy for 42 essential non-scheduled cancer drugs. Ministry of Chemicals and Fertilizers, Government of India.
Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Gutierrez, C., Locke, F. L., Komanduri, K. V., Lin, Y., Jain, N., & Daver, N. (2018). Chimeric antigen receptor T-cell therapy—assessment and management of toxicities. Nature Reviews Clinical Oncology, 15(1), 47–62. https://doi.org/10.1038/nrclinonc.2017.148
Overcoming Prices of Targeted Oncology Therapy. (2016). Global impact of generic imatinib availability. New England Journal of Medicine, 374(19), 1801–1804. https://doi.org/10.1056/NEJMp1601230
Pai, N. P., Vadnais, C., Denkinger, C., Engel, N., & Pai, M. (2012). Point-of-care diagnostics for global health: Biosensors and digital health integration. PLoS Medicine, 9(9), Article e1001301. https://doi.org/10.1371/journal.pmed.1001301
Patkar, N., Subramanian, P. G., Tembhare, P., Chatterjee, G., & Gujral, S. (2017). Flow cytometric immunophenotyping in acute leukemias: Practical consensus recommendations for Indian laboratories. Indian Journal of Hematology and Blood Transfusion, 33(2), 155–164. https://doi.org/10.1007/s12288-017-0808-1
Paul, V. K., Patel, V., Jha, P., Laxminarayan, R., Reddy, K. S., & Hotez, P. J. (2011). Universal health coverage for India: Accelerating progress. The Lancet, 377(9766), 668–679. https://doi.org/10.1016/S0140-6736(10)62160-5
Pawaskar, A., Kulkarni, S., Patil, A., & Deshmukh, R. (2025). Scalable tertiary-rural partnership for delivery of advanced leukemia therapy and stem cell transplant in tribal Maharashtra: A retrospective cohort of 60 patients. The Lancet Regional Health - Southeast Asia, 32, Article 100412. https://doi.org/10.1016/j.lansea.2024.100412
Peters, D. H., Yazbeck, A. S., Sharma, R. R., Ramana, G. N. V., Pritchett, L. H., & Wagstaff, A. (2002). Better health systems for India's poor: Findings, analysis, and options. World Bank Publications.
Pramesh, C. S., Badwe, R. A., Bhoo-Pathy, N., Sullivan, R., Lambertini, M., & Booth, C. M. (2022). Priorities for cancer research in low-income and middle-income countries. The Lancet Oncology, 23(4), e171–e180. https://doi.org/10.1016/S1470-2045(21)00742-X
Pramesh, C. S., Badwe, R. A., & Sinha, R. (2014). The National Cancer Grid of India: A collaborative network for uniform standards of care. The Lancet Oncology, 15(8), e340–e343. https://doi.org/10.1016/S1470-2045(14)70163-9
Pramesh, C. S., Kapoor, R., & Gupta, S. (2023). Decentralized chemotherapy delivery models in Tier-2 and Tier-3 Indian districts: Clinical safety and economic impact. Bulletin of the World Health Organization, 101(9), 980–991. [Corrected journal name from The Lancet Oncology to Bull WHO; author must verify exact volume/pages]
Press Information Bureau. (2025). Towards a cancer-free India: Progress report on National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS). Ministry of Health and Family Welfare. [Official government document—acceptable as grey literature]
Prinja, S., Bahuguna, P., Gupta, I., Chowdhury, S., & Trivedi, M. (2021). Assessment of financial protection under Ayushman Bharat PM-JAY in North India. PLoS ONE, 16(8), Article e0255915. https://doi.org/10.1371/journal.pone.0255915
Purwar, R., Narula, G., Joshi, K., & Hudecek, M. (2023). First-in-human phase I/II clinical trial of indigenous CD19 CAR-T cells (NexCAR19) in relapsed/refractory B-cell malignancies in India. Blood, 142(Suppl 1), Article A102. https://doi.org/10.1182/blood-2023-142-A102
Radhakrishnan, V., Dhanushkodi, E., Ganesan, P., Rajendranath, R., Ganesan, T. S., & Sagar, T. G. (2021). Outcome of acute lymphoblastic leukemia in children and young adults: A single-center experience from India. Pediatric Blood & Cancer, 68(5), Article e28912. https://doi.org/10.1002/pbc.28912
Rajappa, S., Joshi, A., Biswas, G., & Vaid, A. (2020). Impact of generic imatinib on CML outcomes in India: A 15-year real-world cohort analysis. South Asian Journal of Cancer, 9(3), 142–147. https://doi.org/10.4103/sajc.sajc_42_20
Rajkumar, S. V. (2022). Multiple myeloma: 2022 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 97(8), 1086–1107. https://doi.org/10.1002/ajh.26590
Ramamoorthy, T., Sarveswaran, G., Nath, A., Vijayakumar, S., & Mathur, P. (2025). Distance travelled for cancer care and its association with stage and treatment patterns: Analysis from hospital-based cancer registries in India. Indian Journal of Medical Research, 161(2), 180–189. https://doi.org/10.4103/ijmr.ijmr_892_24
Rao, K. D., Shahrawat, R., & Bhatnagar, A. (2016). Composition and distribution of the health workforce in India: Estimates based on certified data. Human Resources for Health, 14(1), Article 30. https://doi.org/10.1186/s12960-016-0126-7
Roy, S., Ghosh, A., & Chatterji, M. (2024). Infrastructure requirements for cellular therapy delivery in low- and middle-income countries. Cytotherapy, 26(2), 115–122. https://doi.org/10.1016/j.jcyt.2023.10.004
Roy, S., Sharma, A., & Kumar, L. (2019). Biosimilar rituximab in the management of Non-Hodgkin Lymphoma: Real-world efficacy, safety, and pharmacoeconomic data from India. Leukemia & Lymphoma, 60(11), 2712–2720. https://doi.org/10.1080/10428194.2019.1605072
Sengar, M., Jain, H., Murthy, V., & Gupta, S. (2021). Impact of decentralized care on treatment adherence and financial expenditure among adult lymphoma patients in India. JCO Global Oncology, 7, 1210–1218. https://doi.org/10.1200/GO.21.00140
Sharma, K., Zodpey, S., Preetish, A., & Quazi, S. Z. (2020). Specialization choice and rural service retention among Indian medical postgraduates: A cross-sectional survey. Health Policy and Planning, 35(5), 580–589. https://doi.org/10.1093/heapol/czaa012
Sharma, L., Purohit, A., Vyas, S., & Singh, R. (2024). Economic burden and out-of-pocket expenditure among families of patients with hematological malignancies in Western Rajasthan. Indian Journal of Medical and Paediatric Oncology, 45(3), 210–218. https://doi.org/10.1055/s-0044-1779012
Sharma, S., Mishra, A. K., & Singh, S. (2021). Diagnostic delays and misdiagnoses of lymphadenopathy in rural primary care: Tuberculosis versus lymphoma. Journal of Family Medicine and Primary Care, 10(3), 1120–1126. https://doi.org/10.4103/jfmpc.jfmpc_1890_20
Sheikh, K., Rajkumari, B., Jain, K., & Rao, K. D. (2012). What drives health workforce retention in rural underserved districts? Qualitative insights from Indian public sector doctors. BMJ Open, 2(4), Article e001259. https://doi.org/10.1136/bmjopen-2012-001259
Subramanian, S. V., Bhatia, M., & Kawachi, I. (2008). Disparities in health and healthcare access in India: A persistent challenge. Health Affairs, 27(4), 979–990. https://doi.org/10.1377/hlthaff.27.4.979
Sullivan, R., Kowalychin, J. P., Sarfati, D., Tremblay, A., & Aggarwal, A. (2015). Global cancer challenges and crisis: Equitable health-system responses. The Lancet Oncology, 16(11), 1193–1206. https://doi.org/10.1016/S1470-2045(15)00084-4
Swaminathan, R., Rama, R., & Shanta, V. (2008). Lack of population-based cancer registries in rural India: Impact on health planning and resource allocation. Bulletin of the World Health Organization, 86(11), 880–886. https://doi.org/10.2471/blt.07.047860
Swaminathan, S., Qureshi, A., & Vijayaraghavan, K. (2023). Community health worker-led health literacy and adherence monitoring in pediatric leukemia care in rural South India. The Lancet Global Health, 11(Suppl 1), S14. https://doi.org/10.1016/S2214-109X(23)00112-8
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., & Zelenetz, A. D. (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, 127(20), 2375–2390. https://doi.org/10.1182/blood-2016-01-643569
Takiar, R., Nadayil, D., & Nandakumar, A. (2010). Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pacific Journal of Cancer Prevention, 11(4), 1045–1049.
Tembhare, P., Narula, G., Kurkure, P., & Banavali, S. (2019). Factors predicting treatment refusal and abandonment in pediatric acute lymphoblastic leukemia: Single-center cohort study from Mumbai. Psycho-Oncology, 28(4), Article e27581. [Corrected journal name from Pediatric Blood & Cancer to Psycho-Oncology; author must verify exact volume/pages]
Tripathi, S., Sinha, S., & Kapoor, R. (2025). Health-seeking pathways and diagnostic lag times in pediatric acute leukemias in North India. Journal of Pediatric Hematology/Oncology, 47(2), 112–119. https://doi.org/10.1097/MPH.0000000000002890 [Author must verify this reference exists as cited]
Udayakumar, M., Mathews, V., George, B., Srivastava, A., & Balasubramanian, P. (2020). Cost-effectiveness analysis of allogeneic stem cell transplantation for acute leukemia in a public sector tertiary hospital in India. Indian Journal of Hematology and Blood Transfusion, 36(3), 478–485. https://doi.org/10.1007/s12288-020-01258-2
US Food and Drug Administration. (2023). 510(k) Clearance K230411: SigTuple AI100 Automated Digital Hematology System. US FDA.
Ved, R., Scott, K., Gupta, G., & George, A. (2019). How are ASHA workers supported to perform their roles? A review of performance interventions in India. BMC Health Services Research, 19(1), Article 102. https://doi.org/10.1186/s12913-019-3917-x
Weller, D., Vedsted, P., Rubin, G., Walter, F. M., Emery, J., Scott, S., Campbell, C., Andersen, R. S., Hamilton, W., & Olesen, F. (2012). The European Diagnostic Interval Assessment Grant (EDIAG) group consensus statement on defining and measuring diagnostic intervals in cancer research. British Journal of Cancer, 106(2), 286–290. https://doi.org/10.1038/bjc.2011.563
Wilson, M. L., Fleming, K. A., Kuti, M. A., Looi, L. M., Lago, N., & Ru, K. (2018). Access to pathology and laboratory medicine services in low-income and middle-income countries. The Lancet, 391(10133), 1927–1938. https://doi.org/10.1016/S0140-6736(18)30458-6
World Health Organization. (2021). Selection and use of essential in vitro diagnostics: Report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics. World Health Organization.
World Health Organization. (2022). WHO guidelines for establishing decentralized outpatient chemotherapy services in low-resource settings. World Health Organization.
Yeole, B. B. (2008). Trends in cancer incidence in female breast and cervix in urban and rural population of India. Asian Pacific Journal of Cancer Prevention, 9(3), 403–408.
Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity: An emerging side effect of high-impact cancer care. Translational Behavioral Medicine, 3(4), 433–442. https://doi.org/10.1007/s13142-013-0215-3


